类风湿关节炎患者达到DAS、SDAI或CDAI缓解但未达布尔缓解的疾病活动度指标差异
该研究基于PREMIER、OPTIMA和DE019三项试验,分析达到布尔、SDAI、CDAI或DAS28(CRP)缓解的比例,并确定限制SDAI、CDAI或DAS28(CRP)缓解患者达到布尔缓解的组分。结果显示61-66%达到SDAI或CDAI缓解的患者也达到布尔缓解,而74-77%达到DAS28(CRP)缓解的患者未达到布尔缓解;PGA差异限制SDAI/CDAI缓解患者达到布尔缓解,而DAS28(CRP)缓解患者受多个指标差异限制。
要点
- 61-66%达到SDAI或CDAI缓解的患者也达到布尔缓解。
- 74-77%达到DAS28(CRP)缓解的患者未达到布尔缓解。
- PGA差异是SDAI/CDAI缓解患者未达布尔缓解的主要限制因素。
核心结论
- SDAI和CDAI缓解与布尔缓解高度一致,PGA差异是主要限制因素,提示这些标准可互换使用。
- DAS28(CRP)缓解患者因多个疾病活动度指标差异而较少达到布尔缓解。
研究设计与样本
- 基于PREMIER和OPTIMA(早期RA)及DE019( established RA)三项试验的数据分析。
- 计算达到布尔、SDAI、CDAI或DAS28(CRP)缓解的患者比例。
- 在试验前52周内首次记录缓解的访视时评估关节计数、CRP、PGA/PhGA、SDAI、DAS28(CRP)和HAQ-DI。
主要发现
- 61-66%达到SDAI或CDAI缓解的患者也达到布尔缓解。
- 74-77%达到DAS28(CRP)缓解的患者未达到布尔缓解。
- 与布尔缓解患者相比,SDAI或CDAI缓解但非布尔缓解患者PGA评分更高。
- DAS28(CRP)缓解但非布尔缓解患者关节计数、PGA和PhGA评分更高。
关键数值与推荐
- 布尔缓解、SDAI、CDAI和DAS28(CRP)缓解的定义依据原文标准。
- 评估指标包括28和66/68关节肿胀/压痛计数、CRP、PGA/PhGA、SDAI、DAS28(CRP)和HAQ-DI。
临床怎么用
- 临床中SDAI或CDAI缓解可考虑与布尔缓解互换使用,但需注意PGA差异。
- DAS28(CRP)缓解患者应综合评估多个疾病活动度指标以判断是否达到布尔缓解。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In patients with rheumatoid arthritis (RA), remission may be assessed by various composite measures. We assessed achievement of remission as defined by Boolean criteria, Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), and 28-joint Disease Activity Score using C-reactive protein (DAS28[CRP]) and determined the components that limit patients in SDAI, CDAI, or DAS28(CRP) remission from achieving Boolean remission. METHODS: The proportions of patients achieving Boolean, SDAI, CDAI, or DAS28(CRP) remission were calculated for 3 trials: PREMIER and OPTIMA in patients with early RA and DE019 in patients with established RA. At the first visit that remission was recorded during the first 52 weeks of the trial, the following were assessed: swollen/tender joint count at 28 and 66/68 joints, CRP, Patient's/Physician's Global Assessment (PGA/PhGA), SDAI, DAS28(CRP), and Health Assessment Questionnaire-Disability Index. RESULTS: The majority of patients (61-66%) who achieved SDAI or CDAI remission also attained Boolean remission. Although DAS28(CRP) remission was most frequently attained, 74-77% of patients in DAS28(CRP) remission did not achieve Boolean remission. Compared with patients in Boolean remission, patients in SDAI or CDAI remission but not Boolean remission had higher PGA scores, while patients with DAS28(CRP) remission but not Boolean remission had higher joint counts, and PGA and PhGA scores. CONCLUSIONS: Differences in PGA limit patients in SDAI/CDAI remission from meeting the Boolean remission criteria, suggesting that these criteria otherwise can be used interchangeably. In contrast, patients in DAS28(CRP) remission are limited by differences in multiple disease activity measures from achieving Boolean remission.
引用
- Aletaha D, Wang X, Zhong S, et al. Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission. Semin Arthritis Rheum. 2019. PMID: 31590930. doi:10.1016/j.semarthrit.2019.09.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。